Endocrine-disrupting chemicals (EDC) are abundant in our environment. A number of EDCs, including bisphenol A (BPA) can bind to the estrogen receptors (ER), ERα and ERβ, and may contribute to estrogen-linked diseases such as breast cancer. Early exposure is of particular concern; many EDCs cross the placenta and infants have measurable levels of, eg, BPA. In addition, infants are frequently fed soy-based formula (SF) that contains phytoestrogens. Effects of combined exposure to xeno- and phytoestrogens are poorly studied. Here, we extensively compared to what extent BPA, genistein, and an extract of infant SF mimic estrogen-induced gene transcription and cell proliferation. We investigated ligand-specific effects on ER activation in HeLa-ERα and ERβ reporter cells; on proliferation, genome-wide gene regulation and non-ER-mediated effects in MCF7 breast cancer cells; and how coexposure influenced these effects. The biological relevance was explored using enrichment analyses of differentially regulated genes and clustering with clinical breast cancer profiles. We demonstrate that coexposure to BPA and genistein, or SF, results in increased functional and transcriptional estrogenic effects. Using statistical modeling, we determine that BPA and phytoestrogens act in an additive manner. The proliferative and transcriptional effects of the tested compounds mimic those of 17β-estradiol, and are abolished by cotreatment with an ER antagonist. Gene expression profiles induced by each compound clustered with poor prognosis breast cancer, indicating that exposure may adversely affect breast cancer prognosis. This study accentuates that coexposure to BPA and soy-based phytoestrogens results in additive estrogenic effects, and may contribute to estrogen-linked diseases, including breast cancer.
Co-combustion of coal and waste in power plants poses both environmental and economic challenges, especially because of the high polychlorinated dibenzo-p-dioxin and furan (PCDD/F) emissions from solid waste. In this study, we performed a series of experiments focusing on the prevention of PCDD/F formation by the use of various inhibitors added to the fuel before combustion. A mixture of lignite coal, solid waste, and poly(vinyl chloride) (PVC) was thermally treated in a laboratory-scale furnace at 400 degrees C. Twenty different additives were investigated at a level of 10 wt% of the total fuel during the experiments. We have divided them into four general groups according to their chemical nature: metal oxides, N-containing compounds, S-containing compounds, and N- and S-containing compounds. The resulting values showed a significant reduction of PCDD/F levels when N- and S-containing compounds were used as additives to the fuel. Principle component analysis (PCA) was used to illustrate the effect of the 20 different inhibitors on the congener patterns emitted. As a result, the most effective inhibitors for PCDD/F formation in flue gases were determined to be (NH4)2SO4 and (NH4)2S2O3; they are inexpensive and nontoxic materials. Both compounds can suppress the formation of toxic compounds such as PCDD/Fs by more than 98-99%, and the most toxic PCDD/F congeners were not detectable in most of the samples. Thus, these compounds were also studied as a lower percentage of the fuel. (NH4)2SO4 resulted in a greater than 90% reduction of PCDD/F even when composing only 3% of the fuel combusted. However, less than 5% (NH4)2S2O3 resulted in far weaker inhibition. The PCDD/F homologue distribution ratio for samples with varying percentages of (NH4)2SO4 and (NH4)2S2O3 was also investigated. Higher percentages of the inhibitors produced a lower percentage of lower chlorinated PCDDs. The opposite effect was found for PCDFs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.